GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Short Percentage of Float

Starpharma Holdings (Starpharma Holdings) Short Percentage of Float


View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Starpharma Holdings's Short Percentage of Float

For the Biotechnology subindustry, Starpharma Holdings's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starpharma Holdings's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starpharma Holdings's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Starpharma Holdings's Short Percentage of Float falls into.


Starpharma Holdings (Starpharma Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Short Percentage of Float
Comparable Companies
ASX:ADO ASX:BIT ASX:PTX ASX:AGN ASX:ACW ASX:EZZ ASX:CYP ASX:LTP ASX:OCC ASX:ATH OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
SPHRF:USA PQ6:Germany SPL:Australia
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Website
https://www.starpharma.com
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.